Sara De Biasi

Dr. Sara De Biasi

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2017 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
ACAndrea Cossarizza
Andrea Cossarizza
HCHyun-Dong Chang
Hyun-Dong Chang
ARAndreas Radbruch
Andreas Radbruch
MAMübeccel Akdis
Mübeccel Akdis
IAImmanuel Andrä
Immanuel Andrä
JZJakob Zimmermann
Jakob Zimmermann
International audienceThe classical model of hematopoiesis established in the mouse postulates that lymphoid cells originate from a founder population of common lymphoid progenitors. Here, using a modeling approach in humanized mice, we showed that human lymphoid development stemmed from distinct populations of CD127(-) and CD127(+) early lymphoid progenitors (ELPs). Combining molecular analyses with in vitro and in vivo functional assays, we demonstrated that CD127(-) and CD127(+) ELPs emerged independently from lympho-mono-dendritic progenitors, responded differently to Notch1 signals, underwent divergent modes of lineage restriction, and displayed both common and specific differentiation potentials. Whereas CD127(-) ELPs comprised precursors of T cells, marginal zone B cells, and natural killer (NK) and innate lymphoid cells (ILCs), CD127(+) ELPs supported production of all NK cell, ILC, and B cell populations but lacked T potential. On the basis of these results, we propose a "two-family" model of human lymphoid development that differs from the prevailing model of hematopoiesis

13 February 2014 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
Marcello PintiMarcello Pinti
Marcello Pinti
ECElisa Cevenini
Elisa Cevenini
MNMilena Nasi
Milena Nasi
SBSara De Biasi
Sara De Biasi
SSStefano Salvioli
Stefano Salvioli
ACAndrea Cossarizza
Andrea Cossarizza

1 January 2011 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
LGLara Gibellini
Lara Gibellini
Marcello PintiMarcello Pinti
Marcello Pinti
MNMilena Nasi
Milena Nasi
JMJonas P. Montagna
Jonas P. Montagna
SBSara De Biasi
Sara De Biasi
ACAndrea Cossarizza
Andrea Cossarizza
Several molecules present in the diet, including flavonoids, can inhibit the growth of cancer cells with an ability to act as “chemopreventers”. Their cancer‐preventive effects have been attributed to various mechanisms, including the induction of cell‐cycle arrest and/or apoptosis as well as the antioxidant functions. The antioxidant activity of chemopreventers has recently received a great interest, essentially because oxidative stress participates in the initiation and progression of different pathological conditions, including cancer. Since antioxidants are capable of preventing oxidative damage, the wide use of natural food‐derived antioxidants is receiving greater attention as potential anti‐carcinogens. Among flavonoids, quercetin (Qu) is considered an excellent free‐radical scavenging antioxidant, even if such an activity strongly depends on the intracellular availability of reduced glutathione. Apart from antioxidant activity, Qu also exerts a direct, pro‐apoptotic effect in tumor cells, and can indeed block the growth of several human cancer cell lines at different phases of the cell cycle. Both these effects have been documented in a wide variety of cellular models as well as in animal models. The high toxicity exerted by Qu on cancer cells perfectly matches with the almost total absence of any damages for normal, non‐transformed cells. In this review we discuss the molecular mechanisms that are based on the biological effects of Qu, and their relevance for human health.

9 August 2016 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PDF file
MNM. Nasi
M. Nasi
SBSara De Biasi
Sara De Biasi
LGL. Gibellini
L. Gibellini
EBE. Bianchini
E. Bianchini
SPS. Pecorini
S. Pecorini
ACAndrea Cossarizza
Andrea Cossarizza

14 June 2010 in Cancers
Verified
Journal Article
Open access
PDF file
LGLara Gibellini
Lara Gibellini
Marcello PintiMarcello Pinti
Marcello Pinti
MNMilena Nasi
Milena Nasi
SBSara De Biasi
Sara De Biasi
ERErika Roat
Erika Roat
ACAndrea Cossarizza
Andrea Cossarizza
A main feature of cancer cells, when compared to normal ones, is a persistent pro-oxidative state that leads to an intrinsic oxidative stress. Cancer cells have higher levels of reactive oxygen species (ROS) than normal cells, and ROS are, in turn, responsible for the maintenance of the cancer phenotype. Persistent ROS stress may induce adaptive stress responses, enabling cancer cells to survive with high levels of ROS and maintain cellular viability. However, excessive ROS levels render cancer cells highly susceptible to quercetin, one of the main dietary flavonoids. Quercetin depletes intracellular glutathione and increases intracellular ROS to a level that can cause cell death.

18 July 2014 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
SSS J Seguin
S J Seguin
FMF F Morelli
F F Morelli
JVJ Vinet
J Vinet
DAD Amore
D Amore
SBSara De Biasi
Sara De Biasi
SCSerena Carra
Serena Carra
Stress granules (SGs) are mRNA-protein aggregates induced during stress, which accumulate in many neurodegenerative diseases. Previously, the autophagy-lysosome pathway and valosin-containing protein (VCP), key players of the protein quality control (PQC), were shown to regulate SG degradation. This is consistent with the idea that PQC may survey and/or assist SG dynamics. However, despite these observations, it is currently unknown whether the PQC actively participates in SG assembly. Here, we describe that inhibition of autophagy, lysosomes and VCP causes defective SG formation after induction. Silencing the VCP co-factors UFD1L and PLAA, which degrade defective ribosomal products (DRIPs) and 60S ribosomes, also impaired SG assembly. Intriguingly, DRIPs and 60S, which are released from disassembling polysomes and are normally excluded from SGs, were significantly retained within SGs in cells with impaired autophagy, lysosome or VCP function. Our results suggest that deregulated autophagy, lysosomal or VCP activities, which occur in several neurodegenerative (VCP-associated) diseases, may alter SG morphology and composition.